28-Jun-2007 - A new study linking aspartame with various cancers has opened the door for interpretation as it calls into question other studies which have suggested the sweetener is anything but dangerous.
28-Jun-2007 - Merck Serono's revised formulation of its top seller Rebif (interferon beta-1a) that offers improved tolerability for multiple sclerosis sufferers has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP).
27-Jun-2007 - Canadian biotech firm SemBioSys Genetics has presented an update on its project to promote plant-derived recombinant human insulin on a commercial scale, expecting to hop directly to Phase II trials early next year.
27-Jun-2007 - SkyePharma's novel controlled-release sleep therapeutic has been licensed by Somnus Therapeutics in an exclusive worldwide development and commercialisation deal.
27-Jun-2007 - Orphan drug Soliris (eculizumab) has been approved by the European Commission and marks the first therapy for a rare and life-threatening blood disease.
27-Jun-2007 - Procter & Gamble (P&G) has announced its intention to outsource the active pharmaceutical ingredient (API) R&D and manufacturing work undertaken at one of its US factories, with resultant closure of the site and job losses.
26-Jun-2007 - Bioxel Pharma is the latest company to submit a Drug Master File (DMF) to the US Food and Drug Administration (FDA) for docetaxel in the lead up to the patent expiring on Sanofi-Aventis' version of the cytotoxic chemical at the end of this year.
26-Jun-2007 - Eli Lilly's once-daily version of its erectile dysfunction treatment Cialis (tadalafil) has been granted approval by the European Commission, giving it a head-start over other ED treatments that are taken on an as-required basis.
25-Jun-2007 - Despite the popularity of transgenics and the potential it is seen to hold for the future of biopharmaceutical production, Viragen has decided to drop development of its OVA system - therapeutic protein production in transgenic hen eggs.
25-Jun-2007 - Another company has jumped on the band wagon to find an innovative way to increase the half-life of therapeutic proteins.
21-Jun-2007 - The International Society for Pharmaceutical Engineering (ISPE) has published its latest industry guide, a revised edition of its manual providing industry guidance on facilities and production of active pharmaceutical ingredients (APIs).
21-Jun-2007 - German biotech company, Greenovation has received a broad ranging US patent for its unique moss-based biopharmaceutical production technology.
21-Jun-2007 - Novartis' has received US approval for its single-tablet combination of the world's two most popular hypertension drugs, taking advantage of rival patent expiries and shoring up its portfolio.
20-Jun-2007 - Modigene has made inroads into its development of long-acting proteins through the use of its Carboxyl Terminal Peptide (CTP) technology.
20-Jun-2007 - CuraGen is shutting its doors on its Connecticut pilot manufacturing facility in a bid to reduce manufacturing capabilities and to focus more on the company's clinical pipeline.
20-Jun-2007 - A novel super adjuvant is to be put to the test as a new seasonal flu vaccine enters Phase I trials, and is expected to offer enhanced immunity and broader protection than other vaccines on the market.
19-Jun-2007 - The US Government is not sneezing at the potential for an influenza pandemic and has awarded two new vaccine manufacturing contracts to keep the sniffles at bay.
19-Jun-2007 - Dutch ingredients firm DSM has announced plans to carve out its anti-infectives business and boost its presence in Asian markets following a review of the active ingredient unit.
19-Jun-2007 - Cosmo Pharmaceuticals is cementing its place in the inflammatory bowel disease (IBD) drug market with eight new drugs in various stages of reformulation using the company's cutting-edge MMX technology, the company announced recently.
14-Jun-2007 - Following last year's contaminated glycerin poisonings in Panama and last month's FDA guidance, US-PharmaTechnologist.com takes a look at the implications of testing for the excipient glycerin in the pharmaceutical supply chain.
13-Jun-2007 - Lonza is building a new plant in its home country to become the only contract manufacturer with large-scale capacity for making highly potent active pharmaceutical ingredients (APIs).
13-Jun-2007 - Solvay today announced plans to increase production of ultra-pure soda ash at it Dombasle, France, site to meet the growing demand in the pharmaceutical industry.
11-Jun-2007 - Ipsen has cancelled its Phase III trial of its sustained-release formulation of triptorelin while it attempts to fine-tune the manufacturing process of the hormone therapy drug.
07-Jun-2007 - The first ever non-steroidal anti-inflammatory drug (NSAID) to be delivered via the nose has been developed, and its makers are heralding it as "an important breakthrough in treating pain".
07-Jun-2007 - Applied Biosystems has entered into a four-year supply agreement with Repligen to receive recombinant Protein A.